Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

Delayed Quote. Delayed  - 07/28 05:31:27 pm
2.55 CHF   -1.92%
07/27 ADDEX THERAPEUT : ADX71441 Demonstrates Positive Results in Highly T..
07/20 ADDEX THERAPEUT : LifeSci Capital Issues Equity Research Report on A..
06/24 ADDEX THERAPEUT : Annual General Meeting Scheduled for 23 June 2016
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/22/2016 07/25/2016 07/26/2016 07/27/2016 07/28/2016 Date
2.63(c) 2.58(c) 2.56(c) 2.6(c) 2.55(c) Last
11 687 9 252 16 377 55 707 4 705 Volume
+3.14% -1.90% -0.78% +1.56% -1.92% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company was founded by Vincent Mutel, Timothy Dyer and Mark Epping-Jordan in May 2002 and is headquartered in Geneva, Switzerland. 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
07/27 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Highly Translatio..
07/20 ADDEX THERAPEUTICS : LifeSci Capital Issues Equity Research Report on Addex Ther..
07/19 ADDEX THERAPEUTICS LTD : LifeSci Capital Initiates Coverage of Addex Therapeutic..
06/24 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
06/24 ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at 2016 Annual Ge..
06/13 ADDEX THERAPEUTICS : mGluR4 and mGluR7 Programs Demonstrate Potential in Preclin..
06/09 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Non-Human Primate..
06/08 ADDEX THERAPEUTICS : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics
06/02 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
06/02 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
More news
Sector news : Biotechnology & Medical Research - NEC
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise -- Update
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
07/27DJAMGEN : Profit Rises 13%, 2016 Outlook Raised
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Timothy Dyer Chief Executive Officer
Vincent M. Lawton Chairman
Sonia Maria Poli Chief Scientific Officer
Raymond George Hill Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD-8.77%35
INCYTE CORPORATION-18.75%16 533
CELLTRION, INC.--.--%10 724
LONZA GROUP AG12.20%9 855
QUINTILES TRANSNATIONA..13.49%9 232
ALKERMES PLC-39.37%7 276
More Results